OVERVIEW

2022 Updated Summary of the Ada Standards of Medical Care for the Treatment of Diabetes is organized by Dietitian Central. This Course has been approved for a maximum of 1.0 Credits.

Date: Mar 08, 2022 (01:00 PM - 02:00 PM EST)
Expiration Date: May 31, 2024

Target Audience: RDs, DTRs, CDCESs

Overview:
Have you seen the 2022 ADA Standards of Medical Care? There are so many changes! From new additions based on the EASD/ADA Consensus report, there are new screening thresholds, new technology components, updates to COVID-19 vaccination recommendations, information about managment of NAFLD and NASH and so much more!

You don't want to miss this webinar if you work with people with diabetes! It's going to be a great session where we review the 2022 standards of medical care, guidelines for screenings, diagnosis, treatment and prevention of diabetes as outlined by American Diabetes Association (ADA) Guidelines. We will also explore medication algorithms for all people with diabetes!

Join us as we review the 2022 standards and focus heavily on current revisions and current standards.

Upon successful completion of this one-hour course, the participant should be able to:
• Identify 2022 recommendations and changes.
• Identify when a person should be screened for DM, know the criteria for DX, and also know current treatment goals and blood sugar monitoring guidelines.
• Determine when an individual needs a medication adjustment based on a medication algorithm.

TARGET AUDIENCE

PhysicianNutritionistsDietitian

SPECIALITIES

Endocrinology, Metabolism and DiabetesNutrition

RELATED ONLINE COURSES

Implications of Post COVID Comorbidities
Apr 22, 2023 | Live Webinar
Mental Health and Law
More actions
US$119
Severe Acute Respiratory Syndrome (SARS)
Text-Based CME
Infectious Disease
3 Contact Hours
More actions
Recorded Course: Comprehensive Update in Management of Diabetes Mellitus and Obesity Including Role of Bariatric Surgery  (2021-10-27)
Oct 27, 2021 - Oct 27, 2024 | Webcast
Bariatric Surgery
5 Contact Hours
More actions
US$119